Publication
How personalised medicine will transform healthcare by 2030: the ICPerMed vision
| dc.contributor.author | Vicente, Astrid M. | |
| dc.contributor.author | Ballensiefen, Wolfgang | |
| dc.contributor.author | Jönsson, Jan-Ingvar | |
| dc.date.accessioned | 2020-09-17T15:21:36Z | |
| dc.date.available | 2020-09-17T15:21:36Z | |
| dc.date.issued | 2020-04-28 | |
| dc.description | Commentary | pt_PT |
| dc.description | The authors of the present Commentary are acting on behalf of ICPerMed. | pt_PT |
| dc.description.abstract | This commentary presents the vision of the International Consortium for Personalised Medicine (ICPerMed) on how personalised medicine (PM) will lead to the next generation of healthcare by 2030. This vision focuses on five perspectives: individual and public engagement, involvement of health professionals, implementation within healthcare systems, health-related data, and the development of sustainable economic models that allow improved therapy, diagnostic and preventive approaches as new healthcare concepts for the benefit of the public. We further identify four pillars representing transversal issues that are crucial for the successful implementation of PM in all perspectives. The implementation of PM will result in more efficient and equitable healthcare, access to modern healthcare methods, and improved control by individuals of their own health data, as well as economic development in the health sector. | pt_PT |
| dc.description.sponsorship | The Coordination and Support Action (CSA) ICPerMed Secretariat receives funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 731366. It is coordinated by the DLR, Germany, with partners from France (French National Funding Agency, ANR), Italy (Italian Ministry of Health), and Spain (Institute of Health Carlos III, ISCIII). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | J Transl Med. 2020 Apr 28;18(1):180. doi: 10.1186/s12967-020-02316-w | pt_PT |
| dc.identifier.doi | 10.1186/s12967-020-02316-w | pt_PT |
| dc.identifier.issn | 1479-5876 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/7207 | |
| dc.language.iso | eng | pt_PT |
| dc.publisher | BMC | pt_PT |
| dc.relation | Secretariat for the International Consortium for Personalised Medicine (IC PerMed) | |
| dc.relation.publisherversion | https://translational-medicine.biomedcentral.com/track/pdf/10.1186/s12967-020-02316-w | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Personalised Medicine | pt_PT |
| dc.subject | ICPerMed | pt_PT |
| dc.subject | Vision for 2030 | pt_PT |
| dc.subject | Healthcare | pt_PT |
| dc.title | How personalised medicine will transform healthcare by 2030: the ICPerMed vision | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Secretariat for the International Consortium for Personalised Medicine (IC PerMed) | |
| oaire.awardURI | info:eu-repo/grantAgreement/EC/H2020/731366/EU | |
| oaire.citation.issue | 1 | pt_PT |
| oaire.citation.startPage | 180 | pt_PT |
| oaire.citation.title | Journal of Translational Medicine | pt_PT |
| oaire.citation.volume | 18 | pt_PT |
| oaire.fundingStream | H2020 | |
| project.funder.identifier | http://doi.org/10.13039/501100008530 | |
| project.funder.name | European Commission | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isProjectOfPublication | 3c8d1aaa-5df1-44d9-833d-136bf2a32551 | |
| relation.isProjectOfPublication.latestForDiscovery | 3c8d1aaa-5df1-44d9-833d-136bf2a32551 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- How personalised medicine will transform.pdf
- Size:
- 859.58 KB
- Format:
- Adobe Portable Document Format
